{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:00:26Z","timestamp":1794873626152,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471049"],"award-info":[{"award-number":["32471049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171132"],"award-info":[{"award-number":["32171132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MC167"],"award-info":[{"award-number":["ZR2021MC167"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02198-7","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:10:12Z","timestamp":1762524612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Activation of the zona incerta GABAergic circuit for the treatment of pain hypersensitivity in Parkinson\u2019s disease mice model"],"prefix":"10.1186","volume":"26","author":[{"given":"Juntao","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2198_CR1","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J et al (2025) Projections for prevalence of parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021. BMJ 388:e080952","journal-title":"BMJ"},{"key":"2198_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14737167.2024.2390042","volume":"25","author":"F van der Meer","year":"2025","unstructured":"van der Meer F, Jorgensen J, Hiligsmann M (2025) Burden of non-motor symptoms of parkinson\u2019s disease: cost-of-illness and quality-of-life estimates through a scoping review. Expert Rev Pharmacoecon Outcomes Res 25:17\u201327","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2198_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s40001-024-01779-7","volume":"29","author":"B Alharbi","year":"2024","unstructured":"Alharbi B, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Alharbi H, Alexiou A et al (2024) Role of GABA pathway in motor and non-motor symptoms in parkinson\u2019s disease: a bidirectional circuit. Eur J Med Res 29:205","journal-title":"Eur J Med Res"},{"key":"2198_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00702-014-1280-5","volume":"122","author":"Q Tong","year":"2015","unstructured":"Tong Q, Xu Q, Xia Q, Yuan Y, Zhang L, Sun H et al (2015) Correlations between plasma levels of amino acids and nonmotor symptoms in parkinson\u2019s disease. J Neural Transm (Vienna) 122:411\u2013417","journal-title":"J Neural Transm (Vienna)"},{"key":"2198_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10334-021-00910-7","volume":"34","author":"Y Song","year":"2021","unstructured":"Song Y, Gong T, Saleh MG, Mikkelsen M, Wang G, Edden RAE (2021) Upper brainstem GABA levels in parkinson\u2019s disease. Magma 34:689\u2013696","journal-title":"Magma"},{"key":"2198_CR6","doi-asserted-by":"publisher","first-page":"103661","DOI":"10.1016\/j.nicl.2024.103661","volume":"43","author":"Y Tian","year":"2024","unstructured":"Tian Y, Geng S, Liu T, Wang Q, Lian J, Lin L et al (2024) Unveiling MRI markers for parkinson\u2019s disease: GABAergic dysfunction and cortical changes. Neuroimage Clin 43:103661","journal-title":"Neuroimage Clin"},{"key":"2198_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0006-8993(96)00915-8","volume":"741","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, Gsell W, Kornhuber J, Jellinger K, Krieger V, Pantucek F et al (1996) A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome. Brain Res 741:142\u2013152","journal-title":"Brain Res"},{"key":"2198_CR8","doi-asserted-by":"crossref","unstructured":"Daniele A, Panza F, Greco A, Logroscino G, Seripa D (2016). Can a positive allosteric modulation of GABAergic receptors improve motor symptoms in patients with Parkinson\u2019s disease? The potential role of zolpidem in the treatment of Parkinson\u2019s Disease. Parkinsons Dis. 2016:2531812","DOI":"10.1155\/2016\/2531812"},{"key":"2198_CR9","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fphar.2019.01294","volume":"10","author":"A Murueta-Goyena","year":"2019","unstructured":"Murueta-Goyena A, Andikoetxea A, G\u00f3mez-Esteban JC, Gabilondo I (2019) Contribution of the GABAergic system to Non-Motor manifestations in premotor and early stages of parkinson\u2019s disease. Front Pharmacol 10:1294","journal-title":"Front Pharmacol"},{"key":"2198_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","volume":"14","author":"J Parkinson","year":"2002","unstructured":"Parkinson J (2002) An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 14:223\u2013236 discussion 222","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2198_CR11","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/brain\/awab001","volume":"144","author":"A Mostofi","year":"2021","unstructured":"Mostofi A, Morgante F, Edwards MJ, Brown P, Pereira EAC (2021) Pain in parkinson\u2019s disease and the role of the subthalamic nucleus. Brain 144:1342\u20131350","journal-title":"Brain"},{"key":"2198_CR12","doi-asserted-by":"crossref","unstructured":"Jost WH, Cattaneo C (2023). Pain in Parkinson\u2019s disease: pathophysiology, classification and treatment. J Integr Neurosci. 22","DOI":"10.31083\/j.jin2205132"},{"key":"2198_CR13","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/ene.13624","volume":"25","author":"A Antonini","year":"2018","unstructured":"Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G et al (2018) Pain in parkinson\u2019s disease: facts and uncertainties. Eur J Neurol 25:917\u2013e969","journal-title":"Eur J Neurol"},{"key":"2198_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2008.12.004","volume":"141","author":"AG Beiske","year":"2009","unstructured":"Beiske AG, Loge JH, R\u00f8nningen A, Svensson E (2009) Pain in parkinson\u2019s disease: prevalence and characteristics. Pain 141:173\u2013177","journal-title":"Pain"},{"issue":"Suppl 1","key":"2198_CR15","first-page":"S98","volume":"25","author":"B Ford","year":"2010","unstructured":"Ford B (2010) Pain in parkinson\u2019s disease. Mov Disord 25(Suppl 1):S98\u2013103","journal-title":"Mov Disord"},{"key":"2198_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrneurol.2012.54","volume":"8","author":"G Wasner","year":"2012","unstructured":"Wasner G, Deuschl G (2012) Pains in Parkinson disease\u2013many syndromes under one umbrella. Nat Rev Neurol 8:284\u2013294","journal-title":"Nat Rev Neurol"},{"key":"2198_CR17","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1212\/01.WNL.0000130455.38550.9D","volume":"62","author":"R Djaldetti","year":"2004","unstructured":"Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D (2004) Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 62:2171\u20132175","journal-title":"Neurology"},{"key":"2198_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2018.06.022","volume":"392","author":"JK Adewusi","year":"2018","unstructured":"Adewusi JK, Hadjivassiliou M, Vinagre-Arag\u00f3n A, O\u2019Connor KR, Khan A, Gr\u00fcnewald RA et al (2018) Peripheral neuropathic pain in idiopathic parkinson\u2019s disease: prevalence and impact on quality of life; a case controlled study. J Neurol Sci 392:3\u20137","journal-title":"J Neurol Sci"},{"key":"2198_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3233\/JPD-140446","volume":"4","author":"LA Uebelacker","year":"2014","unstructured":"Uebelacker LA, Epstein-Lubow G, Lewis T, Broughton MK, Friedman JH (2014) A survey of parkinson\u2019s disease patients: most bothersome symptoms and coping preferences. J Parkinson\u2019s Disease 4:717\u2013723","journal-title":"J Parkinson\u2019s Disease"},{"key":"2198_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10072-014-1942-y","volume":"36","author":"C-J Mao","year":"2014","unstructured":"Mao C-J, Chen J-P, Zhang X-Y, Chen Y, Li S-J, Li J et al (2014) Parkinson\u2019s disease patients with pain suffer from more severe non-motor symptoms. Neurol Sci 36:263\u2013268","journal-title":"Neurol Sci"},{"key":"2198_CR21","doi-asserted-by":"publisher","first-page":"105646","DOI":"10.1016\/j.neubiorev.2024.105646","volume":"161","author":"J Lei","year":"2024","unstructured":"Lei J, Tang LL, You HJ (2024) Pathological pain: Non-motor manifestations in Parkinson disease and its treatment. Neurosci Biobehav Rev 161:105646","journal-title":"Neurosci Biobehav Rev"},{"key":"2198_CR22","doi-asserted-by":"publisher","first-page":"102140","DOI":"10.1016\/j.arr.2023.102140","volume":"93","author":"G Arena","year":"2024","unstructured":"Arena G, Londei F, Ceccarelli F, Ferrucci L, Borra E, Genovesio A (2024) Disentangling the identity of the Zona incerta: a review of the known connections and latest implications. Ageing Res Rev 93:102140","journal-title":"Ageing Res Rev"},{"key":"2198_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2004.08.017","volume":"130","author":"J Mitrofanis","year":"2005","unstructured":"Mitrofanis J (2005) Some certainty for the zone of uncertainty? Exploring the function of the Zona incerta. Neuroscience 130:1\u201315","journal-title":"Neuroscience"},{"key":"2198_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tins.2019.11.007","volume":"43","author":"X Wang","year":"2020","unstructured":"Wang X, Chou XL, Zhang LI, Tao HW (2020) Zona incerta: an integrative node for global behavioral modulation. Trends Neurosci 43:82\u201387","journal-title":"Trends Neurosci"},{"key":"2198_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00415-019-09486-8","volume":"267","author":"K Ossowska","year":"2020","unstructured":"Ossowska K (2020) Zona incerta as a therapeutic target in parkinson\u2019s disease. J Neurol 267:591\u2013606","journal-title":"J Neurol"},{"key":"2198_CR26","doi-asserted-by":"publisher","first-page":"107149","DOI":"10.1016\/j.isci.2023.107149","volume":"26","author":"F Chen","year":"2023","unstructured":"Chen F, Qian J, Cao Z, Li A, Cui J, Shi L et al (2023) Chemogenetic and optogenetic stimulation of Zona incerta GABAergic neurons ameliorates motor impairment in parkinson\u2019s disease. iScience 26:107149","journal-title":"iScience"},{"key":"2198_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/cne.20240","volume":"477","author":"AD Craig","year":"2004","unstructured":"Craig AD (2004) Distribution of trigeminothalamic and spinothalamic lamina I terminations in the macaque monkey. J Comp Neurol 477:119\u2013148","journal-title":"J Comp Neurol"},{"key":"2198_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neulet.2016.08.035","volume":"632","author":"HC Moon","year":"2016","unstructured":"Moon HC, Lee YJ, Cho CB, Park YS (2016) Suppressed GABAergic signaling in the Zona incerta causes neuropathic pain in a thoracic hemisection spinal cord injury rat model. Neurosci Lett 632:55\u201361","journal-title":"Neurosci Lett"},{"key":"2198_CR29","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2147\/JPR.S131104","volume":"10","author":"HC Moon","year":"2017","unstructured":"Moon HC, Park YS (2017) Reduced GABAergic neuronal activity in Zona incerta causes neuropathic pain in a rat sciatic nerve chronic constriction injury model. J Pain Res 10:1125\u20131134","journal-title":"J Pain Res"},{"key":"2198_CR30","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1038\/s41598-021-87873-w","volume":"11","author":"CW Lu","year":"2021","unstructured":"Lu CW, Harper DE, Askari A, Willsey MS, Vu PP, Schrepf AD et al (2021) Stimulation of Zona incerta selectively modulates pain in humans. Sci Rep 11:8924","journal-title":"Sci Rep"},{"key":"2198_CR31","doi-asserted-by":"publisher","first-page":"1240379","DOI":"10.3389\/fpain.2023.1240379","volume":"4","author":"A Askari","year":"2023","unstructured":"Askari A, Lam JLW, Zhu BJ, Lu CW, Chou KL, Wyant KJ et al (2023) Dorsal subthalamic deep brain stimulation improves pain in parkinson\u2019s disease. Front Pain Res (Lausanne) 4:1240379","journal-title":"Front Pain Res (Lausanne)"},{"key":"2198_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1113\/JP276513","volume":"599","author":"KCG de Git","year":"2021","unstructured":"de Git KCG, Hazelhoff EM, Nota MHC, Schele E, Luijendijk MCM, Dickson SL et al (2021) Zona incerta neurons projecting to the ventral tegmental area promote action initiation towards feeding. J Physiol 599:709\u2013724","journal-title":"J Physiol"},{"key":"2198_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s11055-010-9302-8","volume":"40","author":"AI Gorbachevskaya","year":"2010","unstructured":"Gorbachevskaya AI (2010) Connections between the Zona incerta of the dog diencephalon and the substantia nigra, ventral tegmental field, and pedunculopontine tegmental nucleus. Neurosci Behav Physiol 40:603\u2013607","journal-title":"Neurosci Behav Physiol"},{"key":"2198_CR34","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41593-021-00924-3","volume":"24","author":"T Markovic","year":"2021","unstructured":"Markovic T, Pedersen CE, Massaly N, Vachez YM, Ruyle B, Murphy CA et al (2021) Pain induces adaptations in ventral tegmental area dopamine neurons to drive anhedonia-like behavior. Nat Neurosci 24:1601\u20131613","journal-title":"Nat Neurosci"},{"key":"2198_CR35","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1089\/neu.2017.5381","volume":"35","author":"MY Ko","year":"2018","unstructured":"Ko MY, Jang EY, Lee JY, Kim SP, Whang SH, Lee BH et al (2018) The role of ventral tegmental area Gamma-Aminobutyric acid in chronic neuropathic pain after spinal cord injury in rats. J Neurotrauma 35:1755\u20131764","journal-title":"J Neurotrauma"},{"key":"2198_CR36","doi-asserted-by":"publisher","first-page":"174480691875640","DOI":"10.1177\/1744806918756406","volume":"14","author":"M Watanabe","year":"2018","unstructured":"Watanabe M, Narita M, Hamada Y, Yamashita A, Tamura H, Ikegami D et al (2018) Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer. Mol Pain 14:1744806918756406","journal-title":"Mol Pain"},{"key":"2198_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(96)01164-X","volume":"751","author":"NE Saad\u00e9","year":"1997","unstructured":"Saad\u00e9 NE, Atweh SF, Bahuth NB, Jabbur SJ (1997) Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Res 751:1\u201312","journal-title":"Brain Res"},{"key":"2198_CR38","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","volume":"164","author":"S Duty","year":"2011","unstructured":"Duty S, Jenner P (2011) Animal models of parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164:1357\u20131391","journal-title":"Br J Pharmacol"},{"key":"2198_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-019-0104-6","volume":"6","author":"Y Buhidma","year":"2020","unstructured":"Buhidma Y, Rukavina K, Chaudhuri KR, Duty S (2020) Potential of animal models for advancing the Understanding and treatment of pain in parkinson\u2019s disease. NPJ Parkinsons Dis 6:1","journal-title":"NPJ Parkinsons Dis"},{"key":"2198_CR40","doi-asserted-by":"publisher","first-page":"174549","DOI":"10.1016\/j.ejphar.2021.174549","volume":"911","author":"J Qian","year":"2021","unstructured":"Qian J, Tu H, Zhang D, Barksdale AN, Patel KP, Wadman MC et al (2021) Therapeutic effects of masitinib on abnormal mechanoreception in a mouse model of tourniquet-induced extremity ischemia-reperfusion. Eur J Pharmacol 911:174549","journal-title":"Eur J Pharmacol"},{"key":"2198_CR41","doi-asserted-by":"crossref","unstructured":"Chen S-H, Lan B, Zhang Y-Y, Li G-H, Qian Y-L, Hu MX, et al (2025). Activation of Zona incerta gamma-aminobutyric acid-ergic neurons alleviates depression-like and anxiety-like behaviors induced by chronic restraint stress. World J Psychiatry. 15","DOI":"10.5498\/wjp.v15.i2.101807"},{"key":"2198_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0006-8993(01)02213-2","volume":"898","author":"F Sotres-Bay\u00f3n","year":"2001","unstructured":"Sotres-Bay\u00f3n F, Torres-L\u00f3pez E, L\u00f3pez-Avila A, del Angel R, Pellicer F (2001) Lesion and electrical stimulation of the ventral tegmental area modify persistent nociceptive behavior in the rat. Brain Res 898:342\u2013349","journal-title":"Brain Res"},{"key":"2198_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neures.2005.01.005","volume":"52","author":"R Takeda","year":"2005","unstructured":"Takeda R, Ikeda T, Tsuda F, Abe H, Hashiguchi H, Ishida Y et al (2005) Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation. Neurosci Res 52:31\u201336","journal-title":"Neurosci Res"},{"key":"2198_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2008.03.053","volume":"1213","author":"EH Chudler","year":"2008","unstructured":"Chudler EH, Lu Y (2008) Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine. Brain Res 1213:41\u201347","journal-title":"Brain Res"},{"key":"2198_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2019.02.007","volume":"315","author":"RA Domenici","year":"2019","unstructured":"Domenici RA, Campos ACP, Maciel ST, Berzuino MB, Hernandes MS, Fonoff ET et al (2019) Parkinson\u2019s disease and pain: modulation of nociceptive circuitry in a rat model of nigrostriatal lesion. Exp Neurol 315:72\u201381","journal-title":"Exp Neurol"},{"key":"2198_CR46","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.1073\/pnas.1916263117","volume":"117","author":"Y Luan","year":"2020","unstructured":"Luan Y, Tang D, Wu H, Gu W, Wu Y, Cao JL et al (2020) Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice. Proc Natl Acad Sci U S A 117:10045\u201310054","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2198_CR47","doi-asserted-by":"publisher","first-page":"174480691769152","DOI":"10.1177\/1744806917691525","volume":"13","author":"CT Wang","year":"2017","unstructured":"Wang CT, Mao CJ, Zhang XQ, Zhang CY, Lv DJ, Yang YP et al (2017) Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of parkinson\u2019s disease. Mol Pain 13:1744806917691525","journal-title":"Mol Pain"},{"key":"2198_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fneur.2016.00104","volume":"7","author":"X Zhuang","year":"2016","unstructured":"Zhuang X, Chen Y, Zhuang X, Chen T, Xing T, Wang W et al (2016) Contribution of Pro-inflammatory cytokine signaling within midbrain periaqueductal Gray to pain sensitivity in parkinson\u2019s disease via GABAergic pathway. Front Neurol 7:104","journal-title":"Front Neurol"},{"key":"2198_CR49","doi-asserted-by":"publisher","first-page":"898346","DOI":"10.3389\/fncel.2022.898346","volume":"16","author":"Z Farzinpour","year":"2022","unstructured":"Farzinpour Z, Liu A, Cao P, Mao Y, Zhang Z, Jin Y (2022) Microglial engulfment of spines in the ventral Zona incerta regulates Anxiety-Like behaviors in a mouse model of acute pain. Front Cell Neurosci 16:898346","journal-title":"Front Cell Neurosci"},{"key":"2198_CR50","doi-asserted-by":"crossref","unstructured":"Li D, Mai JW, Deng J, Chen L, Fan HT, Zhang WL, et al (2024). A neural circuit from thalamic paraventricular nucleus via zona incerta to periaqueductal gray for the facilitation of neuropathic pain. Neurobiol Dis. 202","DOI":"10.1016\/j.nbd.2024.106699"},{"issue":"46","key":"2198_CR51","doi-asserted-by":"publisher","first-page":"9130","DOI":"10.1523\/JNEUROSCI.1683-19.2019","volume":"39","author":"TTWR Hu","year":"2019","unstructured":"Hu TTWR, Du Y et al (2019) Activation of the intrinsic pain inhibitory circuit from the midcingulate Cg2 to Zona incerta alleviates neuropathic pain. J Neurosci 39(46):9130\u20139144","journal-title":"J Neurosci"},{"key":"2198_CR52","doi-asserted-by":"crossref","unstructured":"Wu FL, Chen SH, Li JN, Zhao LJ, Wu XM, Hong J, et al (2023). Projections from the rostral Zona incerta to the thalamic paraventricular nucleus mediate nociceptive neurotransmission in mice. Metabolites. 13","DOI":"10.3390\/metabo13020226"},{"key":"2198_CR53","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.neuron.2020.04.027","volume":"107","author":"H Wang","year":"2020","unstructured":"Wang H, Dong P, He C, Feng XY, Huang Y, Yang WW et al (2020) Incerta-thalamic circuit controls nocifensive behavior via cannabinoid type 1 receptors. Neuron 107:538\u2013551e537","journal-title":"Neuron"},{"key":"2198_CR54","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1007\/s12035-023-03431-7","volume":"60","author":"J Li","year":"2023","unstructured":"Li J, Peng S, Zhang Y, Ge J, Gao S, Zhu Y et al (2023) Glutamatergic neurons in the Zona incerta modulate pain and itch behaviors in mice. Mol Neurobiol 60:5866\u20135877","journal-title":"Mol Neurobiol"},{"key":"2198_CR55","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s12264-022-00930-w","volume":"38","author":"Y Yang","year":"2022","unstructured":"Yang Y, Jiang T, Jia X, Yuan J, Li X, Gong H (2022) Whole-Brain connectome of GABAergic neurons in the mouse Zona incerta. Neurosci Bull 38:1315\u20131329","journal-title":"Neurosci Bull"},{"key":"2198_CR56","doi-asserted-by":"publisher","first-page":"107812","DOI":"10.1016\/j.celrep.2020.107812","volume":"31","author":"S Huang","year":"2020","unstructured":"Huang S, Zhang Z, Gambeta E, Xu SC, Thomas C, Godfrey N et al (2020) Dopamine inputs from the ventral tegmental area into the medial prefrontal cortex modulate neuropathic Pain-Associated behaviors in mice. Cell Rep 31:107812","journal-title":"Cell Rep"},{"key":"2198_CR57","doi-asserted-by":"crossref","unstructured":"Yang S, Boudier-Rev\u00e9ret M, Choo YJ, Chang MC (2020). Association between chronic pain and alterations in the mesolimbic dopaminergic system. Brain Sci. 10","DOI":"10.3390\/brainsci10100701"},{"key":"2198_CR58","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41593-023-01519-w","volume":"27","author":"Q Song","year":"2024","unstructured":"Song Q, Wei A, Xu H, Gu Y, Jiang Y, Dong N et al (2024) An ACC-VTA-ACC positive-feedback loop mediates the persistence of neuropathic pain and emotional consequences. Nat Neurosci 27:272\u2013285","journal-title":"Nat Neurosci"},{"key":"2198_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cger.2019.09.012","volume":"36","author":"S Ray","year":"2020","unstructured":"Ray S, Agarwal P (2020) Depression and anxiety in Parkinson disease. Clin Geriatr Med 36:93\u2013104","journal-title":"Clin Geriatr Med"},{"key":"2198_CR60","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/mds.10593","volume":"18","author":"T Stefurak","year":"2003","unstructured":"Stefurak T, Mikulis D, Mayberg H, Lang AE, Hevenor S, Pahapill P et al (2003) Deep brain stimulation for parkinson\u2019s disease dissociates mood and motor circuits: a functional MRI case study. Mov Disord 18:1508\u20131516","journal-title":"Mov Disord"},{"key":"2198_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jns.2008.06.012","volume":"273","author":"G Tommasi","year":"2008","unstructured":"Tommasi G, Lanotte M, Albert U, Zibetti M, Castelli L, Maina G et al (2008) Transient acute depressive state induced by subthalamic region stimulation. J Neurol Sci 273:135\u2013138","journal-title":"J Neurol Sci"},{"key":"2198_CR62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1227\/NEU.0b013e31822ea02a","volume":"70","author":"AM Burrows","year":"2012","unstructured":"Burrows AM, Ravin PD, Novak P, Peters ML, Dessureau B, Swearer J et al (2012) Limbic and motor function comparison of deep brain stimulation of the Zona incerta and subthalamic nucleus. Neurosurgery 70:125\u2013130 discussion 130\u2009\u2013\u2009121","journal-title":"Neurosurgery"},{"key":"2198_CR63","doi-asserted-by":"publisher","first-page":"114992","DOI":"10.1016\/j.expneurol.2024.114992","volume":"382","author":"Y Shi","year":"2024","unstructured":"Shi Y, Zhang J, Xiu M, Xie R, Liu Y, Xie J et al (2024) The Zona incerta system: involvement in parkinson\u2019s disease. Exp Neurol 382:114992","journal-title":"Exp Neurol"},{"key":"2198_CR64","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/jnnp.2006.112334","volume":"79","author":"P Plaha","year":"2008","unstructured":"Plaha P, Khan S, Gill SS (2008) Bilateral stimulation of the caudal Zona incerta nucleus for tremor control. J Neurol Neurosurg Psychiatry 79:504\u2013513","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2198_CR65","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/ner.13500","volume":"25","author":"R Stenmark Persson","year":"2022","unstructured":"Stenmark Persson R, Nordin T, Hariz GM, W\u00e5rdell K, Forsgren L, Hariz M et al (2022) Deep brain stimulation of caudal Zona incerta for parkinson\u2019s disease: One-Year Follow-Up and electric field simulations. Neuromodulation 25:935\u2013944","journal-title":"Neuromodulation"},{"key":"2198_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41531-019-0089-1","volume":"5","author":"A Mostofi","year":"2019","unstructured":"Mostofi A, Evans JM, Partington-Smith L, Yu K, Chen C, Silverdale MA (2019) Outcomes from deep brain stimulation targeting subthalamic nucleus and caudal Zona incerta for parkinson\u2019s disease. NPJ Parkinsons Dis 5:17","journal-title":"NPJ Parkinsons Dis"},{"key":"2198_CR67","doi-asserted-by":"crossref","unstructured":"Goossens MG, Larsen LE, Vergaelen M, Wadman W, Van den Haute C, Brackx W, et al (2021). Level of hM4D(Gi) DREADD expression determines inhibitory and neurotoxic effects in the hippocampus. eNeuro. 8","DOI":"10.1523\/ENEURO.0105-21.2021"},{"key":"2198_CR68","doi-asserted-by":"publisher","first-page":"9130","DOI":"10.1523\/JNEUROSCI.1683-19.2019","volume":"39","author":"TT Hu","year":"2019","unstructured":"Hu TT, Wang RR, Du Y, Guo F, Wu YX, Wang Y et al (2019) Activation of the intrinsic pain inhibitory circuit from the midcingulate Cg2 to Zona incerta alleviates neuropathic pain. J Neurosci 39:9130\u20139144","journal-title":"J Neurosci"},{"key":"2198_CR69","doi-asserted-by":"publisher","first-page":"106699","DOI":"10.1016\/j.nbd.2024.106699","volume":"202","author":"D Li","year":"2024","unstructured":"Li D, Mai JW, Deng J, Chen L, Fan HT, Zhang WL et al (2024) A neural circuit from thalamic paraventricular nucleus via Zona incerta to periaqueductal Gray for the facilitation of neuropathic pain. Neurobiol Dis 202:106699","journal-title":"Neurobiol Dis"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02198-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02198-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02198-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:07:52Z","timestamp":1762528072000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-02198-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02198-7","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The care and use of animals, as well as the experimental protocols employed in this study, were approved by the Animal Ethics Committee of Qingdao University. Patient consent was not applicable for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}